Literature DB >> 15802223

Purification and characterization of a single-chain chimeric anti-p185 antibody expressed by CHO-GS system.

Jing Wang1, Yu Shi, Yanqi Liu, Siyi Hu, Jun Ma, Jing Liu, Liansheng Cheng.   

Abstract

Monoclonal antibody A21 reacts specifically with the extracellular domain of p185c-erbB-2 oncoprotein, a member of the epidermal growth factor receptor family. In a previous study, we constructed a single-chain chimeric antibody, assembled using an A21 single-chain Fv antibody and a human IgG1 Fc fragment. In this study, we expressed this chimeric antibody using a CHO-GS system, and developed a simple and efficient method for its purification. After only one step using affinity purification, the recovery rate and purity of the antibody attained was 60 and 91%, respectively. After a second step, using reverse phase HPLC purification, the purity was above 99%. The high purity of the recombinant antibody allowed us to identify a number of its intrinsic molecular properties, including antigen binding activity, measurement of affinity constant, N-terminal sequencing, and mass spectrometer analysis. These results further augment the potential of this recombinant antibody to be a drug candidate for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802223     DOI: 10.1016/j.pep.2004.11.007

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  4 in total

1.  Crystallization and preliminary crystallographic studies of the single-chain variable fragment of antibody chA21 in complex with an N-terminal fragment of ErbB2.

Authors:  Yang Liu; Huihao Zhou; Juanjuan Zhu; Yongxiang Gao; Liwen Niu; Jing Liu; Maikun Teng
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-06-27

2.  Anti-HER-2 engineering antibody ChA21 inhibits growth and induces apoptosis of SK-OV-3 cells.

Authors:  Anli Zhang; Hua Xue; Xiaoguang Ling; Yi Gao; Feng Yang; Liansheng Cheng; Jing Liu; Qiang Wu
Journal:  J Exp Clin Cancer Res       Date:  2010-03-10

3.  Construction and evaluation of a novel humanized HER2-specific chimeric receptor.

Authors:  Meili Sun; Huan Shi; Chuanyong Liu; Jie Liu; Xianqiang Liu; Yuping Sun
Journal:  Breast Cancer Res       Date:  2014-06-11       Impact factor: 6.466

4.  Development and Characterization of a Humanized Anti-HER2 Antibody HuA21 with Potent Anti-Tumor Properties in Breast Cancer Cells.

Authors:  Ruilin Li; Siyi Hu; Yan Chang; Zhihui Zhang; Zhao Zha; Hui Huang; Guodong Shen; Jing Liu; Lihua Song; Wei Wei
Journal:  Int J Mol Sci       Date:  2016-04-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.